Dabrafenib and Trametinib Therapy for Advanced Anaplastic Thyroid Cancer – Real-World Outcomes From UK Centres
C. Lorimer, Leslie Cheng, R. Chandler, Kate Garcez, V. Gill, Kathryn Graham, Warren Grant, S. Sardo Infirri, Jonathan Wadsley, Lucy Wall, Nathalie Webber, Kee H. Wong, Kate Newbold
Topics & Concepts
MedicineDabrafenibAnaplastic thyroid cancerTrametinibInternal medicineConfidence intervalOncologyDiscontinuationThyroid cancerProgression-free survivalSurgeryCancerChemotherapyVemurafenibBiologyMAPK/ERK pathwayMetastatic melanomaCell biologyKinaseThyroid Cancer Diagnosis and TreatmentCancer, Lipids, and MetabolismLung Cancer Treatments and Mutations